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This paper reports the characterization of a new ABC transporter (LtrABC1.1), related to the human ABCA subfamily, in the protozoan
parasite Leishmania tropica. LtrABC1.1 is a tandem duplicated gene flanked by inverted repeats. LtrABC1.1 is expressed mainly in the
flagellar pocket of the parasite. Drug resistance studies in Leishmania overexpressing LtrABC1.1 showed the transporter not to confer
resistance to a range of unrelated drugs. LtrABC1.1 appears to be involved in lipid movements across the plasma membrane of the parasite
since overexpression reduces the accumulation of fluorescent phospholipid analogues. The activity of this protein may also affect membrane
movement processes since secreted acid phosphatase (SAP) activity was significantly lower in promastigotes overexpressing LtrABC1.1. In
vitro infection experiments with macrophages indicated LtrABC1.1-transfected parasites to be significantly less infective. Together, these
results suggest that this new ABC transporter could play a role in lipid movements across the plasma membrane, and that its activity might
influence vesicle trafficking. This is the first ABCA-like transporter described in unicellular eukaryotes.D 2003 Elsevier Science B.V. All rights reserved.Keywords: ABC transporter; Leishmania; Phospholipid trafficking1. Introduction
Leishmania is a pathogenic, kinetoplastid, protozoan
parasite, and is responsible for leishmaniasis. Its life cycle
involves a flagellated promastigote form that lives in the
insect vector, and intracellular amastigote forms that inhabit
the vertebrate host. According to the World Health Organ-
ization, around 350 million people are exposed to the risk of
infection by different species of Leishmania; the disease
currently affects 12 million people and has an annual
incidence of 2 million. Unfortunately, chemotherapy is
confronted with ever more frequent cases of resistance.
Usually, the resistant parasites amplify portions of the
genome containing resistance genes, some of which encode
members of the ATP binding cassette (ABC) family of0005-2736/03/$ - see front matter D 2003 Elsevier Science B.V. All rights reserv
doi:10.1016/S0005-2736(03)00131-7
Abbreviations: ABC, ATP binding cassette; NBD1, nucleotide-binding
domain 1; NBD2, nucleotide-binding domain 2; PS, phosphatidylserine;
PC, phosphatidylcholine; PE, phosphatidylethanolamine; PL, phospholi-
pids; C6-NBD-, [N-(7-nitrobenzo-2-oxa-1,3-diazol-4-yl)amino]
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E-mail address: castanys@ipb.csic.es (S. Castanys).transporters. For example, Leishmania tarentolae selected
in vitro for resistance to arsenicals and antimonials amplifies
the H circle containing the PGPA gene [1]. It has been
suggested that this transporter is expressed in the mem-
branes of an intracellular compartment where these drugs
are accumulated [2]. When selected stepwise for resistance
to daunomycin, Leishmania tropica amplifies and overex-
press the MDR1-like gene as part of an extrachromosomal
element [3]. The latter confers multidrug resistance (MDR)
similar to that observed in tumour cells, which includes
resistance to the alkyl-lysophospholipids miltefosine (hex-
adecylphosphocholine) and edelfosine (1-O-octadecyl-2-O-
methyl-glycerophosphocholine), often considered promis-
ing anti-Leishmania agents [3,4].
ABC transporters are thought to be one of the largest of
protein families, and they may have been present throughout
evolution (see Ref. [5] for a review). They transport a range
of structurally unrelated compounds using ATP hydrolysis
as their energy source. These transporters are composed of
two transmembrane domains (TMD1 and TMD2) and two
nucleotide-binding domains (NBD1 and NBD2) that contain
the conserved Walker A and Walker B motifs as well as theed.
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proteins that have been organized into seven subfamilies
http://www.med.rug.nl/mdl/humanabc.htm.). In recent
years, it has been observed that several ABC transporters
are involved in lipid movements across cell membranes [6].
This activity therefore influences several biological pro-
cesses such as drug transport or the production of bile [6].
The members of the ABCA subfamily are an example of
ABC transporters involved in lipid trafficking. One of the
most characterized member of this subfamily, ABCA1, has
a major role in cholesterol and phospholipid efflux across
the plasma membrane [7]. Mutations in ABCA1 are respon-
sible for Tangier disease and familial HDL deficiency,
disorders characterized by the almost complete absence of
plasma HDL, cholesteryl ester accumulation in tissue mac-
rophages, and low levels of plasma apolipoproteins [8–11].
In addition, ABCA1 is proposed to be involved in the
engulfment and clearance of apoptotic cells [12] through
the ability to expose phosphatidylserine (PS) on the external
face of the plasma membrane [13].
Until now, only ABC transporters related to the human
ABCB and ABCC subfamilies have been studied in Leish-
mania [14]. The present work reports sequences coding for
ABCA-like transporters and describes the molecular and
initial functional characterization of the LtrABC1.1 gene of
L. tropica. LtrABC1.1 appears to be involved in phospho-
lipid trafficking across the plasma membrane of the parasite,
an activity that seems to influence other cellular processes
such as infectivity.2. Materials and methods
2.1. Parasite cell culture
The parasite cell lines used in this study were Leishmania
infantum strain 21578 (LEM 2592, Montpellier, France) and
L. tropica strain LRC-L39 (LEM 2563, Montpellier,
France). Promastigotes were grown in vitro at 28 jC in
modified RPMI-1640 medium (Gibco BRL) supplementedFig. 1. Restriction map of the recombinant clone phage containing LtrABC1.1. Th
fragments subcloned into the pBluescript-KS vector. Fragments used as probes in S
repeat sequence. (2) Probe for 5Vend of LtrABC1.1. (3) Probe for NBD1 of LtrAB
LtrABC1.1. (5) Probe for NBD2 of LtrABC1.1. Arrows indicate the position of th
LtrABC1.2.with 20% heat-inactivated foetal bovine serum (FBS)
(Gibco BRL) as previously described [15]. Promastigote
cultures were initiated at 4 106 cells ml 1 and collected
during the logarithmic phase of growth. For infection
studies, parasites were collected during the stationary phase
of growth. The transfected cell line (LABC1N) was cloned
in solid medium containing RPMI plus 20% FBS/1% agar
with 500 Ag ml 1 of G418 at 28 jC. Isolated colonies were
obtained after 10 days and transferred into liquid medium in
the presence of G418.
2.2. Drug susceptibility assay
Drug susceptibilities were determined using a 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrasodium bromide
(MTT)-based assay as previously described [16]. Briefly,
log phase promastigotes in fresh medium were deposited
(3 105 cells/well) in 96-well plastic plates and maintained
for 72 h at 28 jC in the presence of different concentrations
of drug compounds. After incubation, 0.5 mg ml 1 medium
of MTT was added to each well, and the plates further
incubated for 4 h. Finally, water-insoluble formazan crystals
were dissolved by adding SDS, and absorbance was meas-
ured at 540 nm in a microplate reader (Beckman Biomek
2000). Cell viability was determined by dividing the absorb-
ance at a given drug concentration by the absorbance of
control cells grown in the absence of the drug.
2.3. Library screening and LtrABC1.1 cloning
A EEMBL3 genomic library of L. tropica was used for
ABCA-like gene screening. Approximately 160,000 pfu of
this library were transferred to nitrocellulose membranes
(Schleicher & Schuell) and probed with a partial cDNA
sequence for a putative ABCA-like transporter of Trypano-
soma cruzi (23A18 clone, accession number AI057758)
kindly provided by Dr. L. Aslund (Uppsala University,
Sweden). A recombinant phage containing a 13,271-bp
insert was then selected. Different fragments of this insert
(see Fig. 1) were subcloned in the pBluescript II KS+ vectore major restriction sites employed for cloning are indicated. Below: Distinct
outhern blot analysis are shown below as solid lines. (1) Probe for inverted
C1.1. (4) Probe for extracytoplasmic loop, defined as the specific probe for
e inverted repeat sequence. Left—sequence corresponding to the 3Vend of
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plasmid contained a 4kb SalI/XhoI fragment corresponding
to the 5Vend of the insert, pKSXH contained the adjacent 5
kb XhoI/HindIII fragment, pKS3.4 contained an overlapping
3 kb BglII fragment, and pKS2.5 contained an overlapping
2.5 kb SalI fragment corresponding to the 3Vend of the
phage insert. Nucleotide sequences were determined auto-
matically as described by Lario et al. [17] using the ABI
PRISM Big Dyek Terminator Cycle Sequencing Ready
Reaction (Applied Biosystems).
2.4. DNA constructs and transfection procedures
Plasmid constructs used for transfections were derived
from the pX vector [18] with a modified polylinker
(pKSNEOA). This plasmid contained the neomycin phos-
photransferase gene (NEO) flanked by the 5Vand 3Vin-
intergenic regions from the dihydrofolate reductase/thy-
midilate synthetase (DHFR-TS) gene. To construct plasmid
bearing LtrABC1.1 flanked with its natural 5Vand
3Vuntranslated regions (UTRs), the following steps were
performed. The pKS2.5 plasmid was digested with SalI and
DraI and the 1500 bp resulting fragment containing the
3Vend of LtrABC1.1 and 218 bp of 3VUTR was subcloned
into the SalI/EcoRV site of the pBluescript II KS+ vector.
Part of the subcloned fragment was substituted by a 2600-bp
BstEII/XbaI fragment of pKS2.5 containing the 3Vend of the
gene and a more extensive 3Vnoncoding sequence. A 1800-
bp SalI fragment from pKS3.4 plasmid was inserted into SalI
site of the previous plasmid. Finally, a 5000-bp XhoI/HindIII
fragment of pKSXH containing the 5Vportion of LtrABC1.1
and its 5VUTR was added. The resulting construct, named
LABC1, bore the LtrABC1.1 ORF flanked by 2171 bp of the
5Vand 1360 bp of the 3Vnoncoding sequences. For expres-
sion in Leishmania, the NEO cassette of the pKSNEOA
vector was inserted into the XhoI site of the LABC1 plasmid,
resulting in the LABC1N plasmid. For transformation,
5 107 promastigotes of L. infantum were resuspended in
400 Al HBS buffer (21 mM HEPES, 137 mM NaCl, 5 mM
KCl, 7 mM Na2HPO4, 6 mM glucose, pH 7.4) and trans-
fected with 100 Ag of LABC1N and pKSNEOA plasmids by
electroporation at 450 V, 1300 AF, 13 Vs (BTX ElectroCell
Manipulator 600). Transfected parasites were grown in the
usual growth medium in the presence of continually increas-
ing concentrations of G418 (Gibco BRL) until a final
concentration of 2 mg ml 1.
2.5. Southern and Northern analysis
Genomic DNA was extracted from Leishmania with the
‘‘Puregene DNA isolation’’ kit (Gentra). Following the
separation of digested total DNA on 0.8% agarose gel, the
DNA was transferred to Hybond-N nylon membranes
(Amersham) by standard methods [19]. Chromosome-sized
DNA was separated by CHEF gel electrophoresis in a 1%
agarose gel with 1 TBE (100 mM Tris, 90 mM boric acid,1 mM EDTA) as previously described [3]. Gels were trans-
ferred as described above. RNA was obtained using Trizol
reagent (Gibco BRL). The poly (A+) fraction was obtained
using the Quick Prep Micro mRNA Purification kit (Phar-
macia) and electrophoresis was performed on denaturing
gels containing formaldehyde. Filters were hybridized with
a a32P-dCTP random-primed labelled probes prepared from
gel-isolated DNA fragments using the Gene Clean kit of Bio
101 Inc. Quantification was performed with an Instant
Imager (Packard). The probes (see Fig. 1) employed in
Southern, Northern and CHEF blot analyses were obtained
as follows. Probe no. 3, corresponding to the sequence for
NBD1 of LtrABC1.1, was obtained after digestion of the
pKSXH plasmid with BamHI and HindIII enzymes. Probe
no. 5, corresponding to the sequence for NBD2, was
obtained after digestion with BstEII/BglII of the pKS2.5
plasmid. Specific probe no. 4 for LtrABC1.1 was obtained
by PCR from pKS3.4 by using LABC1-23 (5V-AG-
CACGCCGACGATCGTG) and LABC1-24 (5V-CGTACA-
GAGATGACTCCAC) primers. Probe no. 1 (which searches
for inverted repeats) was obtained from PCR amplification
of pKSXH with LABC1-26 (5V-GATCGTCGGCAC-
GATTCG) and LABC1-27 (5V-GATGACGCCCAC-
CACCTC) oligonucleotides. Probe no. 2, corresponding to
the 5Vend of LtrABC1.1, was obtained after EcoRI digestion
of the pKSXH plasmid. The NEO probe was obtained from
the pKSNEOA plasmid after digestion with SpeI.
2.6. RT-PCR
The splice acceptor and polyadenylation sites of the
ABC1.1 transcript were determined by RT-PCR using
poly(A+) RNA as a template. cDNAs were generated using
a specific antisense 5Vprimer (LABC1-11) corresponding to
655–673 nucleotides of the LtrABC1.1 sequence (5V-
GACTCGAAAGGGAATCTC) or an ANCH+ oligo(dT)
primer (5V-CCTCTGAAGGTTCCAGAATCGATAG-
GAATTC(T)18VN) and M-MLV reverse transcriptase
(Gibco BRL). The cDNAs were further amplified with the
specific 5Vantisense LABC1-20 (5V-TCATCGGAGAG-
TACTCGC) or the 3VLABC1-3 (5V-TGTCGAGCGTGTT-
CACTG) primers in combination with either a spliced leader
(LSL) primer (5V-AACGCTATATAAGTATCAG) or the
ANCH primer (5V-CCTCTGAAGGTTCCAGAATCGATA).
The 3Vamplification products were reamplified with a 3V
primer corresponding to the noncoding sequence (5V-
GGTCGCGTGAGTGAACTTG). PCR products were
cloned into pGEM-T (Promega) and sequenced.
2.7. Antibodies to LtrABC1.1 and Western blot analysis
The recombinant protein corresponding to the region
between the 7th and 8th transmembrane segments of
LtrABC1.1, fused to a sequence for six histidines, was
expressed in bacteria. It was then purified in a Ni2 +-NTA
column. Polyclonal antiserum was obtained by several
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bits with 150 Ag of purified recombinant peptide. The IgG
fraction was obtained by passing the antiserum through a
protein A-Sepharose CL-4B column (Pharmacia). For
immunoblots, crude Leishmania extracts were prepared
by suspending the washed parasites in urea cracking buffer
(10 mM sodium phosphate pH 7, 1% h-mercaptoethanol,
1% SDS, 5M urea) at a concentration of 109 parasites
ml 1. Total cell proteins were separated on 10% poly-
acrylamide-SDS gel and electrotransferred onto immobi-
lon-P membranes (Millipore) using a semi-dry blot
apparatus (Hoefer Sci. Inst.). For immunodetection, mem-
branes were incubated for 1 h at room temperature with a
1/5000 dilution of the anti-LtrABC1.1 immune serum in
buffer A [PBS/1% bovine serum albumin (BSA)]contain-
ing 0.05% Tween-20. After washing twice with buffer A,
the membranes were incubated for 30 min with phospha-
tase-conjugated goat anti-rabbit IgG antibodies (Sigma),
washed twice, and then revealed with 5-bromo-4-chloro-3-
indolyl phosphate and nitroblue tetrazolium substrates
(Boehringer Mannheim).
2.8. Indirect immunofluorescence microscopy
Parasites (2 106 ml 1) were harvested, washed five
times in cold PBS, and allowed to settle onto slides with ten
6-mm-diameter circles. Fixation was allowed to proceed
sequentially at  20 jC in ethanol for 5 min and in acetone
for 8 min. The slides were then incubated with antibody
against LtrABC1.1 (dilution 1/200) or preimmune serum for
1 h at 37 jC. After three washes in PBS/0.5% BSA, the
slides were further incubated with FITC-conjugated goat
anti-rabbit IgG (Sigma) for 1 h at 37 jC and washed as
above. After mounting with Vectashield (Vecta Laboratories
Inc.), the slides were observed using an epifluorescent
microscopy Zeiss Axiophot (Germany). Images were cap-
tured with a SPOT camera (Diagnostic Instruments, Inc.)
and analyzed using Adobe Photoshop 5.5 software.
2.9. Phospholipid analogue accumulation and flow
cytometry analysis
Parasites (8 106 ml 1) were preincubated in HPMI
buffer (20 mM HEPES, 132 mM NaCl, 3.5 mM KCl, 0.5
mM MgCl2, 5 mM glucose, 1 mM CaCl2, pH 7.25) plus
0.3% BSA and 500 AM phenylmethylsulfonylfluoride for
30 min at 28 jC. In some cases, the parasites were
preincubated in the absence of glucose and in the presence
of 10 mM sodium azide (NaN3) or 0.5 mM N-ethylmalei-
mide. The parasites were then incubated with 2 AM of [N-
(7-nitrobenzo-2-oxa-1,3-diazol-4-yl)amino] (C6-NBD)-PS,
phosphatidylcholine (PC), or phosphatidylethanolamine
(PE) (Avanti Polar Lipids) for 30 min at 28 jC or at 0 jC
in HPMI plus 0.3% BSA. After washing twice with cold
PBS, samples were maintained on ice and the cellular
fluorescence measured. Flow cytometric analysis of C6-NBD-PL accumulation in parasites was performed with a
FACScan flow cytometer (Becton-Dickinson, San Jose´, CA)
equipped with an argon laser operating at 488 nm and using
Cell Quest software. The experimental population was
mapped using a two-parameter histogram of forward-angle
light scatter versus side scatter. The mapped population was
then analyzed for log green fluorescence (FL1) using a
single-parameter histogram.
2.10. In vitro infection of macrophages
Before infection with parasites, macrophages from the
J774G8 line were seeded into 24-well microtiter plates
(20,000 cell/well) containing 12-mm coverslips and RPMI
1640 medium plus 10% FBS for 72 h. The macrophages
were infected at 35 jC with stationary-phase promastigotes
(metacyclic) of control and LtrABC1.1-transfected L. infan-
tum at a ratio of 1:20 (cells/parasites). After 6 h, excess
parasites were removed by washing with serum-free
medium. The infected macrophages were further incubated
in RPMI 1640 medium plus 10% FBS for 72 h at 37 jC in a
5% CO2 atmosphere to allow intracellular parasite prolifer-
ation. After the incubation period, the cultures were fixed in
methanol, stained with Giemsa, and the percentage of
internalized parasites determined by light microscopy. Three
independent experiments were performed with duplicates.
The Student’s t-test was used for the statistical analysis of
data.
2.11. Secreted acid phosphatase (SAP) assay
To follow exocytosis, SAP activity was assayed daily in
200 Al of supernatants from Leishmania cultures starting
with 2 106 parasites ml 1, using p-nitrophenyl phosphate
(Sigma) as a substrate, as previously described [20]. The
assay was performed for 30 min at 37 jC. After the
incubation period, the reaction was stopped with 800 Al of
0.25M NaOH and measured in a spectrophotometer at 410
nm. The results were expressed in nanomoles of substrate
hydrolyzed per minute per milliliter (extinction coefficient:
17.8 mM 1).3. Results
3.1. Identification and characterization of LtrABC1.1
In order to identify genes related to the ABCA sub-
family of transporters described in humans, a EEMBL3 L.
tropica library was screened. This was performed using the
23A18 probe, a partial coding sequence for a putative
ABCA-like transporter of the related protozoan parasite
T. cruzi. Some 160,000 clones of the genomic library were
plated and nearly 100 hybridized with the 23A18 probe.
Twenty-four were plaque-purified for further characteriza-
tion. Based on the restriction pattern shown by these
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restriction fragments with the 23A18 probe, a E clone
named 2B1 with an approximately 14-kb-long insert con-
taining a full-length ABC gene was selected. After the
subcloning of four overlapping fragments of this insert in
the pBluescript II KS+ vector (see experimental procedures
and Fig. 1), the complete sequence was determined. The
open reading frame (ORF) included within this insert
comprises 5529 bp and codes for a 1843 amino acid
protein with a predicted molecular weight of approximatelyFig. 2. Predicted sequence of LtrABC1.1. Putative transmembrane segments (TM
numbered. Walker A (WA) and Walker B (WB) motifs are boxed and ABC fam
positions of TMD1 and TMD2 as well as NBD1 and NBD2. Right—amino acid200 kDa. The sequence of this gene, named LtrABC1.1,
has been submitted to GenBank (accession no. AF200948).
A search of sequence databases using the FASTA algorithm
revealed the deduced amino acid sequence of LtrABC1.1 to
best match with the ABC transporters of the human ABCA
subfamily. LtrABC1.1 shared around 32% identity with
human ABCA4 and ABCA1 and 28% with CED7 of
Caenorhabditis elegans. When the homology of NBDs—
the most conserved regions of these proteins—was com-
pared, NBD1 of LtrABC1.1 was found to have 50%), predicted by the Kyte and Doolittle algorithm [21], are underlined and
ily signature motifs double-underlined. Left—vertical lines represent the
positions are indicated.
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identity values reached 48% and 49%, respectively. In
contrast, the alignment of LtrABC1.1 NBDs with other
ABC transporters, such as human ABCB and ABCC
subfamilies, revealed less than 25% identity. Analysis of
the deduced amino acid sequence and prediction of the
secondary structure [21] showed it to be a complete ABC
protein with two TMDs and two NBDs (Fig. 2). Each
TMD was composed of six hydrophobic segments. Within
each, there was a stretch of 200–250 amino acids between
the first two hydrophobic segments, predicting a large
extracytoplasmic loop region (see Fig. 2). Similar mem-
brane topology has been proposed for ABCA4 and other
ABCA proteins [22]. It seems to be a characteristic feature
of the ABCA subfamily that is absent in other ABC
transporter subclasses.
3.2. LtrABC1.1 is duplicated in tandem
Restriction mapping of the insert of the 2B1 clone
suggested the presence of a 3Vcoding region of another
ABC gene. This was further confirmed by sequencing. The
sequence is located upstream of LtrABC1.1 and is truncated
by one phage arm of the recombinant clone (see Fig. 1 for a
schematic representation). At the nucleotide level, the 1100-
bp partial sequence of this gene is very similar to the
3Vregion of LtrABC1.1, except at the 3Vend where it lacks
the last six codons. In addition, there are five point changes
that give rise to three changes in the predicted amino acid
sequence (not shown). Given their proximity and their high
sequence similarity, these two genes probably represent aFig. 3. Genomic organization and chromosomal localization of LtrABC1.1 and A
DNA of L. tropica digested with restriction enzymes that do not cut the probe a
EcoRI; (3) EcoRI/HindIII; (4) HindIII; (5) BglII; (6) HindIII/BglII. The molecular
blot analysis of genomic DNA of L. tropica digested with BspEI/EcoRI (1), Bsp
hybridized with the NBD1 (left) and NBD2 (right) probes of LtrABC1.1. (C) Sou
digested with BspEI/EcoRV hybridized with the NBD1 (left) and NBD2 (right) pro
L. braziliensis; (5) L. tarentolae. (D) CHEF analysis of L. tropica hybridized wi
specific probe for LtrABC1.1 (right). O represents origin of electrophoresis. Thetandem duplication. Consequently, this gene was named
LtrABC1.2. The tandem duplication of LtrABC1.1 was
confirmed by Southern blot analysis using a specific probe
for LtrABC1.1 (the loop region located between the 7th and
8th transmembrane segments of the protein; probe number
no. 4 in Fig. 1) (Fig. 3A). Further, analysis of sequences
contained in the GenBank database revealed a cosmid
sequence of Leishmania major (accession number
AC098845) harbouring an ORF corresponding to
LtrABC1.2. Sequence comparison revealed nearly 90%
similarity at the nucleotide level between this and
LtrABC1.1. The differences mainly lie at the 3V(as described
between LtrABC1.1 and LtrABC1.2) and 5Vends. Since
genes from different species of Leishmania were compared,
it can be predicted that LtrABC1.1 and LtrABC1.2 are very
similar.
3.3. Identification of an inverted repeat sequence flanking
LtrABC1.1
Analysis of the nucleotide sequence of the recombinant
2B1 clone revealed the presence of a perfect inverted repeat
(IR) on both sides of the coding region of LtrABC1.1. The
extension of this IR could not be determined because the
sequence located at the 3Vend was truncated by the phage
arm. However, the IR sequence is at least 219 nucleotides
long. Southern blot analysis (with probe no. 1 of Fig. 1),
performed to determine whether this belonged to a family of
Leishmania repeat sequences, revealed it to be only infre-
quently repeated in the Leishmania genome (data not
shown). Accordingly, after searching the LeishmaniaBCA-like genes in Leishmania sp. (A) Southern blot analysis of genomic
nd hybridized with the specific probe for LtrABC1.1. Lanes: (1) ApaI; (2)
weight marker was lambda phage DNA digested with HindIII. (B) Southern
EI/EcoRV (2), BspEI/BamHI (3), enzymes that do not cut the probes, and
thern blot analysis of genomic DNA from different species of Leishmania
bes of LtrABC1.1. Lanes: (1) L. tropica; (2) L. infantum; (3) L. donovani; (4)
th the NBD2 probe, which recognizes all ABCA-like genes (left), and the
molecular weight marker was S. cerevisiae chromosomes from BioLabs.
Fig. 4. Processing sites of mRNA of LtrABC1.1. (A) The acceptor splicing
AG dinucleotides at positions  443 and  463 from the translation
initiation site are in bold and underlined. The polypyrimidine tract
preceding the spliced leader acceptors are underlined. Underlined ATG
indicates the start of LtrABC1.1. (B) The sites for polyadenylation at
positions + 246 and + 248 downstream of stop codon (underlined) are in
bold and are underlined.
A. Parodi-Talice et al. / Biochimica et Biophysica Acta 1612 (2003) 195–207 201genome database, no significant homology with any
described sequences was seen for this IR.
3.4. Several sequences related to ABCA-like transporters
are present in the genome of Leishmania
Since LtrABC1.1 was found to be duplicated in tandem,
experiments were performed to see whether there were any
other sequences related to LtrABC1.1 in the genome of L.
tropica. Southern blot analysis using as probes conserved
ABC transporter sequences such as those of the NBD1 and
NBD2 of LtrABC1.1 (probes no. 3 and no. 5, respectively,
in Fig. 1), revealed several fragments. This supports the
existence of a number of genes related to LtrABC1.1 (Fig.
3B). Further, to determine whether this subfamily was
represented by several members in other Leishmania spe-
cies, we compared the hybridization patterns of the L.
tropica, L. infantum, L. donovani, L. braziliensis and L.
tarentolae genomes (after digestion with restriction enzymes
that did not cut the probes and following hybridization with
the NBD1 and NBD2 probes of LtrABC1.1). As observed in
Fig. 3C, several fragments were recognized in all the species
analyzed. These probably correspond to different genes.
These results support the presence in Leishmania of a
subfamily of transporters related to the human ABCA
subfamily.
The chromosomal localization of this subfamily of trans-
porters was then studied. The hybridization pattern of
chromosomal bands of L. tropica was examined by clamped
homogeneous electric field (CHEF) analysis using either the
NBD2 probe or the specific LtrABC1.1 probe (probes no. 5
and no. 4, respectively, in Fig. 1). The NBD2 probe
hybridized with two chromosomal bands of 1.3 and 0.6
Mb, whereas the LtrABC1.1 probe hybridized with the
largest band (Fig. 3D). These results indicate that
LtrABC1.1 lies on a 1.3 Mb chromosome while the other
ABCA-like genes must lie on the smallest chromosome.
3.5. Expression and processing of ABC1.1 mRNA
The mRNA expression of ABC1.1 was analyzed by
Northern blotting. No transcript was detected in wild-type
promastigotes of L. tropica or L. infantum when 40 Ag of
total RNA or 5 Ag of the poly(A)+ RNA fraction were
blotted and hybridized with the LtrABC1.1-specific probe.
This indicates that it is a low-expression gene. Indeed, RT-
PCR experiments performed with RNA from L. infantum
showed the presence of ABC1.1 mRNA. The 5Vand 3V
processing sites in the mRNA of ABC1.1 were then
characterized. To locate the spliced leader addition sites of
ABC1.1, cDNA was synthesized from promastigotes by
reverse transcription. This was amplified with spliced leader
primer (LSL) and antisense primer (LABC1-20) (which
hybridizes to a region 163 nucleotide downstream of the
ATG triplet of ABC1.1). Two different trans-splicing sites
were identified as shown in Fig. 4A, located 443 and 463nucleotide upstream from the putative translation initiation
site of ABC1.1. For the identification of the polyadenylation
sites, a similar strategy was used. cDNA was synthesized
with an antisense primer consisting of a stretch of poly T
fused to an anch sequence (ANCH+T), and was amplified
with an ANCH primer and an antisense primer correspond-
ing to the 3Vend of ABC1.1 (LABC1-3). To increase
specificity, amplification products were further amplified
using a primer of the 3Vnoncoding region of ABC1.1. Two
polyadenylation sites of ABC1.1 were identified 246 and
248 nucleotide downstream of the stop codon (see Fig. 4B).
From these results, it can be deduced that the mRNA of
LtrABC1.1 is 6240 nucleotide long, with a 5VUTR at least
443 nucleotide long and a 3VUTR at least 246 nucleotide
long.
3.6. Obtaining parasites overexpressing LtrABC1.1
To study functional aspects of the LtrABC1.1 transporter,
Leishmania parasites were obtained that overexpress
LtrABC1.1. Since the L. tropica strain usually maintained
in our laboratory had lost its infectivity, LtrABC1.1 was
transfected into the more infective L. infantum. In Leishma-
nia, it is known that UTRs often determine the expression
efficiency or stability of mRNA. Accordingly, in the con-
struction of the expression plasmid, the natural 5Vand 3V
noncoding regions of LtrABC1.1 were included. After trans-
fection, the presence of the episomal gene was revealed by
cleaving of total DNA of transfected parasites with BamHI
Fig. 6. LtrABC1.1 expression in Leishmania. Lanes: (1) parasites
transfected with the pKSNEOA plasmid; (2) parasites transfected with
the LABC1N plasmid. (A) Proteins stained with Coomassie Blue as loading
control. (B) Western blot analysis of total proteins from transfected
A. Parodi-Talice et al. / Biochimica et Biophysica Acta 1612 (2003) 195–207202and hybridizing with the 5Vend probe of LtrABC1.1 (probe
2 in Fig. 1). Since BamHI cleaves LtrABC1.1 and also the
3Vend of the NEO cassette, two hybridization bands were
expected corresponding to the episomal and genomic genes
in the lanes containing the DNA of transfected cell lines
(Fig. 5A). Using quantitative Southern blot analysis, it was
found that LABC1N-transfected parasites have around 80
gene copies. Northern blot analysis showed overexpression
of a transcript longer than 6 kb corresponding to LtrABC1.1
in parasites transfected with the LABC1N plasmid (Fig.
5B).
3.7. Expression and localization of LtrABC1.1
To obtain specific antibodies against LtrABC1.1, the
region spanning the loop between the 7th and 8th trans-
membrane segments was selected. Amino acid sequence
alignment of the ABCA subfamily identified this region as
the most divergent (data not shown). Consequently, it was
expected that antibodies against this polypeptide would
recognize only ABC1.1 in Leishmania. Polyclonal anti-
serum against this region of LtrABC1.1 was obtained and parasites with antiserum raised with LtrABC1.1. Molecular mass standards
(kDa) are from Bio-Rad.
Fig. 5. Molecular characterization of transfected parasites. Lanes: (1)
control parasites transfected with the pKSNEOA plasmid; (2) parasites
transfected with the LABC1N plasmid. (A) Southern blot analysis of
genomic DNA digested with BamHI from control and LtrABC1.1-
transfected parasites hybridized with the 5Vprobe of LtrABC1.1. Thin
arrows indicate hybridization bands of genomic copies of ABC1.1; thick
arrows indicate episomal hybridization bands. The molecular weight
marker was lambda DNA digested with HindIII. (B) Northern blot analysis
of total RNA from control and LtrABC1.1-transfected parasites, hybridized
with the specific probe for LtrABC1.1. Arrow indicates position of
LtrABC1.1 transcript. Lower panel corresponds to the same blot reprobed
with the NEO probe to monitor its transcript levels. The final panel
corresponds to ethidium bromide staining for monitoring the quantities of
RNA.its specificity confirmed by Western blot of cell lysates
from control and LtrABC1.1-transfected logarithmic pro-
mastigotes. As observed in Fig. 6, the antiserum detected a
band of around 200 kDa in transfected parasites over-
expressing LtrABC1.1. This band was weakly perceptible
in control transfected parasites. To determine whether this
protein was differentially expressed during promastigote
growth, LtrABC1.1 expression levels were examined
throughout the logarithmic and stationary phases. No
changes were observed in expression levels (data not
shown). To determine the subcellular localization of
LtrABC1.1, indirect immunofluorescence was performed
with LtrABC1.1-transfected promastigotes. Antiserum
against LtrABC1.1 predominantly stained the flagellar
pocket but also the plasma membrane and flagellum
(Fig. 7B,D) in parasites transfected with the LABC1N
plasmid. Control transfected parasites showed a faint stain,
also mainly located in the flagellar pocket (Fig. 7A,C). No
fluorescence was observed with a rabbit preimmune serum
(not shown).
3.8. Drug resistance profiles of Leishmania overexpressing
LtrABC1.1
Since some ABC transporters are involved in drug
resistance in Leishmania, the question arose as to whether
LtrABC1.1 overexpression could confer resistance to differ-
ent compounds. Different unrelated drugs were tested
including some antileishmanial agents such as the alkyl-
lysophospholipids edelfosine and miltefosine, ketoconazole
and amphotericin B, and other known ABC substrates or
Fig. 8. C6-NBD-PL accumulation. Parasites were incubated with short-
chain fluorescent analogues of phospholipids at 28 jC or on ice (with
glucose), or at 28 jC in the presence of 10 mM NaN3 (without glucose).
Cell-associated fluorescence was measured by flow cytometry analysis. A
representative histogram is shown for each analogue. The grey histogram
represents control transfected cells, the uncoloured histogram that of
LtrABC1.1-transfected parasites.
Fig. 7. Immunofluorescence localization of LtrABC1.1 in Leishmania promastigotes. Parasites overexpressing LtrABC1.1 were stained with anti-LtrABC1.1
polyclonal rabbit antiserum followed by fluorescein-conjugated secondary antibody. (A and C) Parasites transfected with control plasmid. (B and D) Parasites
transfected with the LABC1N plasmid. Conditions of exposure were forced to visualize label in control cells. Arrowheads indicate region of flagellar pocket.
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and glyburide. LtrABC1.1 was found to confer resistance to
none of the drugs tested (data not shown).
3.9. Accumulation of fluorescent phospholipid analogues
To study the possible involvement of LtrABC1.1 in lipid
transport, phospholipid accumulation was examined using
short-chain fluorescent labelled phospholipids. Parasites
were previously incubated in the presence of phenylmethyl-
sulfonylfluoride to maintain labelled phospholipid integrity,
and then incubated with C6-NBD-PS, C6-NBD-PE or C6-
NBD-PC for 30 min at 28 jC and the cell-associated
fluorescence analyzed by flow cytometry. Under these
conditions, the accumulation of the three assayed analogues
was significantly lower in LtrABC1.1-overexpressing cells
(Fig. 8). Thus, the accumulation differences observed may
be a consequence of the activity of LtrABC1.1. To assess
this, cells were loaded with C6-NBD-phospholipids (C6-
NBD-PL) in an accumulation experiment performed under
different conditions. While accumulation of C6-NBD-PL at
28 jC with glucose was lower in transfected than in control
parasites (ratios values of 2.5F 0.3 for PC, 2.5F 0.3 for PE,
and 1.9F 0.1 for PS, n = 3), C6-NBD-PL accumulation at 0
jC or in the presence of NaN3 were similar for both lines
(see Fig. 8). Similarly, no differences were observed when
accumulation of C6-NBD-PC occurred in the presence of
the sulfhydryl modifying reagent N-ethylmaleimide (data
not shown). These results strongly suggest that the activityof LtrABC1.1 is responsible for the observed differences in
phospholipid accumulation.
3.10. LtrABC1.1 overexpression leads to a decrease in the
infectivity of Leishmania
Based on the results concerning the involvement of
LtrABC1.1 in phospholipid trafficking across plasma mem-
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influence the infective capacity of Leishmania. In vitro
infection experiments using a J774G8 macrophage cell
line were therefore performed. Parasites overexpressing
LtrABC1.1 were significantly (P < 0.005) less infective
(11.8F 4.2%) compared to transfected controls (29.1F
2.7%) while the ratios of number of parasites/cells were
similar in both lines. The low infectivity showed by these
transfected parasites is not due to an intrinsic characteristic of
the clone employed in these studies since the noncloned
parental line also showed low infectivity (not shown).
3.11. Vesicle trafficking may be modified in LtrABC1.1
transfected parasites
The significantly lower infectivity of parasites overex-
pressing LtrABC1.1 may be due to altered expression, at the
parasite surface, of molecules involved in the interaction
with and/or invasion of parasites into host cells. To inves-
tigate this, the exocytosis process of these parasites was
studied. Secretion of acid phosphatases of Leishmania hasFig. 9. SAP activity in Leishmania overexpressing LtrABC1.1. Bars
represent the SAP activity in Leishmania promastigotes as nanomoles
pNPP hydrolyzed per minute per milliliter (right scale). The line plot
represents the growth rate of parasites over culture time (left scale). (A)
Control-transfected parasites. (B) LABC1N-transfected parasites. Data are
means of two independent experiments performed in duplicateF S.D.been studied extensively and it has been employed as a
marker for the secretory pathway [20,23]. The analysis of
SAP activity, as a measure of exocytosis, indicated that
parasites transfected with LtrABC1.1 showed a significantly
lower SAP activity with respect to transfected control para-
sites (Fig. 9). Transfected noncloned parental line also
showed a similar lower SAP activity (not shown). These
results indicate that the exocytosis pathway is modified in
LtrABC1.1-transfected organisms.4. Discussion
This work identifies a new ABC transporter in the
protozoan parasite Leishmania. Sequence homology com-
parison of LtrABC1.1 suggests that this transporter is
related to the ABCA subfamily described in humans. The
hydropathy profile of LtrABC1.1 is similar to that of other
ABCA transporters, which predicts a particular membrane
topology for this group, characterized by these proteins
having a very large exocytoplasmic domain in both their
N- and C-terminal halves [22]. This is the first report of an
ABCA-like transporter in unicellular eukaryotes. It is note-
worthy that, until now, it was thought that this subfamily
was confined to multicellular eukaryotic organisms. No
sequence related to this subfamily of transporters has been
found in the complete sequenced genome of Saccharomyces
cerevisiae. Since the order Kinetoplastidae, to which Leish-
mania belongs, is thought to have diverged very early
during eukaryotic evolution, the presence of this subfamily
in Leishmania raises the question of whether yeasts have
lost genes encoding transporters related to the ABCA
subfamily during their evolution. It is possible that functions
normally carried out by these transporters have been
acquired by others proteins of the ABC family.
4.1. Genomic and chromosomal organization of the ABCA-
like genes of Leishmania
This study reveals that in the Leishmania genome, there
are several sequences related to the ABCA-like transporters.
Southern blot analysis and the examination of sequences
deposited in the database of the Leishmania genome project
http://www.ebi.ac.uk/parasites/leish.html) support the pres-
ence of at least four genes related to the ABCA subfamily.
Checking for the presence of these genes in several species
of Leishmania revealed this subfamily to be conserved and
to be represented by several genes in all the species studied.
The presence of the LtrABC1.1 and LtrABC1.2 genes in
tandem and the high degree of sequence similarity between
them are consistent with gene duplication and sequence
divergence. Similarly, a high degree of similarity suggests
that both gene products may have similar functions in the
parasite.
LtrABC1.1 ORF is flanked on both sides by an IR
sequence that is conserved at the nucleotide level. It is
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which are involved in recombination processes that give
rise to genomic rearrangements finally resulting in amplifi-
cation of particular chromosomal regions [24]. Therefore,
the locus containing LtrABC1.1 might be considered a ‘‘hot
site’’ that suffers rearrangements under particular circum-
stances, for example when under drug pressure. Indeed,
Leishmania is very efficient at using directed and inverted
repeat sequences to induce amplicons, as in the H circle [1].
It has been demonstrated that, in vitro, the H circle is
amplified using repeat sequences as a response to drugs
[25]. However, LtrABC1.1 does not seem to be a resistant
gene since no correlation between resistance and LtrABC1.1
expression was observed with the unrelated compounds
tested in this study.
LtrABC1.1 appears to be a low-expression gene since its
mRNA is not revealed in Northern blot analysis. However,
RT-PCR studies for identifying the processing sites at the 5V
and 3Vends revealed that this gene is indeed expressed in
Leishmania promastigotes. Therefore, to know the function
of this ABC transporter in Leishmania, transfected parasites
that overexpress LtrABC1.1 were obtained. Since the 5Vand
3VUTRs of Leishmania genes are important for suitable
expression, the natural 5Vand 3Vnoncoding regions of
LtrABC1.1 gene were included in the plasmid construct.
This might account for the good expression level obtained
with this construct.
4.2. Role of LtrABC1.1 in lipid and vesicle trafficking
The results presented here provide evidence that
LtrABC1.1 is involved in lipid transport across the plasma
membrane of this parasite. The Leishmania line overex-
pressing LtrABC1.1 showed significantly less accumulation
of C6-NBD analogues of phospholipids. In fact, accumu-
lation levels reverted to values similar to those of control
cells when accumulation was performed on ice or in the
presence of sodium azide (conditions that inhibit energy-
dependent protein activities). Similar results were obtained
when C6-NBD-PC accumulation was performed in the
presence of the sulfydryl modifying agent N-ethylmalei-
mide, further supporting the idea that the accumulation
differences observed are the consequence of protein activ-
ities. It has been reported that the mammalian ABC trans-
porters Mdr1 and Mdr2 function as lipid floppases.
However, while Mdr2 has been described as a PC trans-
locator, Mdr1 appears to be a more general phospholipid
transporter [26]. Similarly, the activity of LtrABC1.1
appears to be independent of the polar heads of phospho-
lipids since parasites overexpressing this protein accumu-
lated less of all three analogues tested (PS, PC and PE). It is
striking that LtrABC1.1-transfected parasites do not show
resistance to the ether lipid edelfosine, which is structurally
similar to the ester lipid C6-NBD-PC. However, structural
differences between these two compounds might explain the
absence of resistance. LtrABC1.1 may be responsible forthe decreased accumulation of phospholipid analogues as
a consequence of efflux activity across the plasma mem-
brane or through facilitating the sorting and packaging of
lipids into their transport vesicles for exocytosis from cells,
as proposed for mammalian ABCA1 [27]. ABCA1 is
involved in an apolipoprotein-mediated lipid efflux pathway
(reviewed in Ref. [28]) and its activity also influences
vesicle trafficking. For example, it has been described that
ABCA1 induces the rearrangement of actin cytoskeletons
through the possible interaction with the Cdc42/N-WASP
pathway [29]. Besides, it has been demonstrated that the
expression of members of the Rho GTPase family is altered
in cells from Tangier disease patients [30,31]. All these
observations suggest that ABCA1 is involved in vesicular
transport through interaction with the components of this
pathway. In fact, endocytosis is enhanced in Tangier cells
[32]. It is noteworthy that LtrABC1.1 protein appears to be
predominantly expressed at the flagellar pocket and that this
region is thought to be the sole site for exocytosis and
endocytosis in Leishmania [33]. It is therefore possible that
at this location, LtrABC1.1 may regulate membrane move-
ments such as endocytosis, exocytosis and vesicle traffick-
ing. Indeed, in this study, it was observed that exocytosis
(measured as SAP activity) in parasites overexpressing
LtrABC1.1 is altered. These findings could explain why
parasites overexpressing LtrABC1.1 are less infective than
controls. It is suggested that altered vesicle traffic would
result in surface alterations where specific molecules, some
involved in the infection process, may be affected. It has
been proposed that ABCA1 functions as a PS floppase [13].
However, the lipid substrates for this transporter have not
yet been clearly defined, and it has been proposed that
ABCA1 may be a protein with regulatory functions that
directs membrane trafficking [34,35]. In Leishmania, it
remains to be clarified whether LtrABC1.1 is a primary
transporter that directly translocates phospholipids across
the plasma membrane or whether it is a secondary trans-
porter with mainly regulatory functions.
The majority of eukaryotic cell membranes are asym-
metric in phospholipid distribution across the bilayer, and
loss of asymmetry in multicellular organisms (which indu-
ces the surface exposure of PS) triggers important biological
events such as the coagulation cascade in platelets, the
recognition and clearance of apoptotic cells by phagocytic
cells, and lymphocyte differentiation [36]. However, little is
know about the physiological significance of phospholipid
distribution and movement in unicellular organisms such as
Leishmania. It is possible that the membrane lipids and
protein machinery have specific functions in parasite differ-
entiation and/or infectivity.Acknowledgements
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